Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M127Revenue (TTM) $M42.0Net Margin (%)-0.2Altman Z-Score-1.9
Enterprise Value $M127EPS (TTM) $-0.0Operating Margin %-90.7Piotroski F-Score2
P/E(ttm)--Beneish M-Score2.8Pre-tax Margin (%)-38.2Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsN
Price/Sales3.05-y EBITDA Growth Rate %--Current Ratio1.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-0.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-1.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M55.3ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BDSI

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BDSI is held by these investors:



BDSI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sirgo Mark APresident, CEO & Vice Chairman 2017-03-31Sell110,895$1.923.68view
De Paolantonio Ernest RobertCFO, Secretary and Treasurer 2017-03-23Sell170$1.923.68view
Vasisht NirajSVP & Chief Technology Officer 2017-03-23Sell530$1.923.68view
ODONNELL FRANCIS E JRDirector 2017-03-23Sell750$1.923.68view
Vasisht NirajSVP & Chief Technology Officer 2017-03-01Sell42,000$1.9818.69view
De Paolantonio Ernest RobertSee Remarks 2017-03-01Sell19,750$1.9719.29view
ODONNELL FRANCIS E JRDirector 2017-02-17Sell129,860$1.9123.04view
Vasisht NirajSee Remarks 2017-01-30Sell6,905$1.9123.04view
SEARS SAMUEL P JRDirector 2016-12-01Sell12,000$1.6740.72view
Feinberg Barry IDirector 2016-11-23Buy2,000$1.6740.72view

Quarterly/Annual Reports about BDSI:

News about BDSI:

Articles On GuruFocus.com
/C O R R E C T I O N -- BioDelivery Sciences International, Inc./ May 15 2017 
BioDelivery Sciences Reports First Quarter 2017 Financial Results and Provides Corporate Update May 15 2017 
BioDelivery Sciences to Host Conference Call and Webcast Reporting First Quarter 2017 Financial Resu May 09 2017 
BioDelivery Sciences Announces the Approval of BUNAVAIL® for Induction of Buprenorphine Treatment f May 02 2017 
BioDelivery Sciences to Present at the Deutsche Bank 42nd Annual Health Care Conference Apr 26 2017 
BioDelivery Sciences Announces the Granting of Two New Patents to be Listed in FDA's Orange Book Fur Mar 31 2017 
Weekly CFO Buys Highlight: BioDelivery Sciences International, TheStreet, Antares Pharma Mar 27 2016 
Weekly CEO Sells Highlight: Vringo Inc, Medivation Inc, BioDelivery Sciences International Inc and H Feb 02 2014 
Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX Jul 17 2012 
BioDelivery Sciences International Inc. Reports Operating Results (10-K/A) Nov 19 2010 

More From Other Websites
Edited Transcript of BDSI earnings conference call or presentation 15-May-17 8:30pm GMT May 21 2017
BioDelivery Sciences International (BDSI) Jumps: Stock Up 5% May 18 2017
BDSI CEO on Belbuca revenue potential: We're on an upward trend May 16 2017
BioDelivery (BDSI) Q1 Earnings Beat Estimates, Stock Gains May 16 2017
/C O R R E C T I O N -- BioDelivery Sciences International, Inc./ May 15 2017
BioDelivery tops Street 1Q forecasts May 15 2017
Investor Network: BioDelivery Sciences International, Inc. to Host Earnings Call May 15 2017
BioDelivery Sciences to Host Conference Call and Webcast Reporting First Quarter 2017 Financial... May 09 2017
What's in Store for BioDelivery (BDSI) this Earnings Season? May 08 2017
BDSI's expanded approval of opioid dependence drug required few resources, exec says May 03 2017
BioDelivery Sciences Announces the Approval of BUNAVAIL® for Induction of Buprenorphine Treatment... May 02 2017
BioDelivery Sciences to Present at the Deutsche Bank 42nd Annual Health Care Conference Apr 26 2017
BioDelivery (BDSI) Down 15% Since Earnings Report: Can It Rebound? Apr 18 2017
New cash, patents boost optimism at Raleigh's BioDelivery Sciences Apr 04 2017
BioDelivery to Grant New Patents for its Marketed Drugs Apr 03 2017
Blog Coverage BioDelivery Extends its Patent Portfolio; Acquires Extended Patents for BELBUCA,... Apr 03 2017
BioDelivery Sciences Secures Two Patents Mar 31 2017
BioDelivery Sciences Announces the Granting of Two New Patents to be Listed in FDA's Orange Book... Mar 31 2017
BioDelivery Sciences International and Rexahn Pharmaceuticals See Share Values Rise Slightly Mar 28 2017
BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet Mar 20 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat